Century Therapeutics Stock Price on April 26, 2024
| IPSC Stock | USD 1.10 0.05 4.76% |
If you're considering investing in Century Stock, it is important to understand the factors that can impact its price. As of today, the current price of Century Therapeutics stands at 1.10, as last reported on the 22nd of December, with the highest price reaching 1.12 and the lowest price hitting 1.05 during the day. Century Therapeutics secures Sharpe Ratio (or Efficiency) of -0.074, which signifies that the company had a -0.074% return per unit of risk over the last 3 months. Century Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Century Therapeutics' Standard Deviation of 5.36, risk adjusted performance of (0.07), and Mean Deviation of 4.08 to double-check the risk estimate we provide.
At present, Century Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 15.4 M, whereas Common Stock Total Equity is forecasted to decline to 3,575. . At present, Century Therapeutics' Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.12, whereas Price To Sales Ratio is forecasted to decline to 58.04. Century Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Century |
Sharpe Ratio = -0.074
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IPSC |
Estimated Market Risk
| 5.3 actual daily | 47 53% of assets are more volatile |
Expected Return
| -0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Century Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Century Therapeutics by adding Century Therapeutics to a well-diversified portfolio.
Price Book 0.4736 | Enterprise Value Ebitda 0.0752 | Price Sales 34.848 | Shares Float 28.6 M | Wall Street Target Price 9.6667 |
Century Therapeutics Main Headline on 26th of April 2024
Acquisition by Adrienne Farid of 30684 shares of Century The... by Adrienne Farid
Filed transaction by Century Therapeutics Officer Chief Operations Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Century Therapeutics Valuation on April 26, 2024
It is possible to determine the worth of Century Therapeutics on a given historical date. On April 26, 2024 Century was worth 3.22 at the beginning of the trading date compared to the closed value of 2.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Century Therapeutics stock. Still, in general, we apply an absolute valuation method to find Century Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Century Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Century Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.88 | 3.18 | 2.85 | 3.15 | 116,059 | |
04/26/2024 | 3.22 | 3.25 | 2.82 | 2.88 | 161,095 |
| 2.88 | 3.45 | 2.88 | 3.05 | 102,231 |
| Backtest Century Therapeutics | | | Century Therapeutics History | | | Century Therapeutics Valuation | Previous | Next |
Century Therapeutics Trading Date Momentum on April 26, 2024
| On April 29 2024 Century Therapeutics was traded for 3.05 at the closing time. The top price for the day was 3.45 and the lowest listed price was 2.88 . The trading volume for the day was 102.2 K. The trading history from April 29, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 5.90% . The overall trading delta against the current closing price is 7.64% . |
Century Therapeutics Fundamentals Correlations and Trends
By evaluating Century Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Century Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Century financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Century Therapeutics Stock history
Century Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Century is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Century Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Century Therapeutics stock prices may prove useful in developing a viable investing in Century Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 59.3 M | 62 M | |
| Net Loss | -150.6 M | -158.1 M |
Century Therapeutics Quarterly Net Working Capital |
|
Century Therapeutics Stock Technical Analysis
Century Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Century Therapeutics Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Century Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Century Therapeutics December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Century Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Century Therapeutics shares will generate the highest return on investment. By undertsting and applying Century Therapeutics stock market strength indicators, traders can identify Century Therapeutics entry and exit signals to maximize returns
Century Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Century Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Century Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Century to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.19) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Century Stock analysis
When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |